Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

New treatments targeting T-cell pathways are needed for better alopecia areata management.

The conclusion is that understanding the complex relationship between allergies, autoimmunity, and psychological factors is key to treating skin disorders with itching.

Higher social status is linked to earlier diagnosis and better treatment results for Frontal Fibrosing Alopecia in women.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

Detoxil effectively treats chronic skin conditions by improving liver detoxification and reducing symptoms.

Treating gum disease and stress may help improve alopecia.

In Denmark from 1995 to 2016, hospital-treated alopecia areata cases increased, mostly affecting women and those over 50.

PlacMA hydrogels from human placenta are versatile and useful for cell culture and tissue engineering.

A woman on immunosuppressants developed two rare scalp conditions, which improved with specific treatments.

Higher BMI may increase the risk of psoriasis and some other skin diseases.

Immune checkpoint inhibitors used in cancer therapy can cause hair loss, and understanding this can help manage the side effect.

Targeted immunotherapies may offer better treatment for alopecia areata by controlling inflammation and immune responses.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

T cells affect skin cell genes in inflammatory diseases, and therapy can normalize these changes.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

Bullous pemphigoid, intrahepatic cholangiocarcinoma, and alopecia areata may share immune-related causes.

IL-18 levels are higher in hidradenitis suppurativa patients and may indicate disease severity.

JAK inhibitors effectively treat skin conditions and topical forms are safer.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

IL-4 and IL-13 might play a role in a type of hair loss similar to alopecia areata.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

Autoimmune diseases with high tissue recovery often relapse and remit, while those with low recovery rarely remit.

Inflammation and immunity play a key role in androgenetic alopecia, with better treatment outcomes in certain immune-positive cases.

CD18-deficient mice developed psoriasis-like skin disease, useful for studying inflammatory skin disorders.

Nucleic acids trigger chemokine production in skin cells, affecting skin inflammation.

Targeting Interleukin-13 could help treat alopecia areata linked with atopic dermatitis.

Children with frequent severe infections and low antibodies should be checked for immune deficiencies.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Inflammation is a key factor in heart disease and targeting it can reduce heart problems.